Insider Activity Highlights a Shift in National HealthCare Corp’s Ownership Dynamics

On March 16, 2026, Senior Vice President of Patient Services Vicki L. Dodson executed a series of transactions that shed light on the broader insider sentiment around National HealthCare Corp (NHCC). She exercised a sizeable block of options granted under the 2020 Omnibus Equity Incentive Plan, converting 3,734 shares at $53.94 per share and immediately selling 2,034 shares at $164.96. The net effect was a modest purchase of 3,734 shares, increasing her post‑transaction holdings to 16,446.55 shares. This pattern—buying option‑derived shares at a low exercise price and then selling them at a higher market value—indicates confidence in the company’s long‑term trajectory while allowing her to lock in gains on her incentive awards.

Implications for Investors and the Company’s Outlook

Dodson’s activity comes against a backdrop of a near‑flat share price ($162.67) and a modest weekly gain of 0.88%. Her actions, combined with a broader trend of insider buying by the CEO and CFO, suggest that senior management is willing to stake out a longer‑term position. In an industry where capital intensity and regulatory pressure are mounting, such insider confidence can be a positive signal for value investors. However, the company’s recent earnings slide—an 80% drop in first‑half net profit—remains a concern. The insiders’ buying may reflect an expectation that operational discipline and cost‑control initiatives will eventually translate into earnings rebound, but investors should monitor the company’s ability to turn around its revenue decline.

Dodson Vicki L. – A Consistent Long‑Term Stakeholder

Over the past two years, Dodson has maintained a steady accumulation of options and shares. Her holdings have grown from 3,734 shares in March 2024 to 16,446.55 shares as of March 2026. The pattern of exercising options early and selling at a premium indicates a disciplined approach to equity compensation. She has also held sizable option positions—8,000 shares in March 2025 and 9,000 shares in March 2026—showing a willingness to lock in future upside. This consistency underscores her belief in the company’s strategic direction, particularly its expansion into long‑term care and home‑care services, which align with demographic trends favoring elder care.

Broader Insider Activity – A Mixed Signal

While Dodson’s buying is noteworthy, other key insiders exhibit mixed behavior. CEO Stephen Fowler has both purchased and sold shares in March 2026, reflecting a balanced approach. CFO Brian Kidd’s activity includes substantial buying but also option selling, suggesting a strategy to diversify holdings. The combined insider activity shows a blend of confidence and risk mitigation—an important context for investors weighing the potential for upside against the company’s current earnings challenges.

Key Takeaway for Stakeholders

National HealthCare Corp’s insiders are actively managing their equity positions, with Dodson Vicki L.’s recent transaction signaling confidence in the company’s long‑term strategy. For investors, this insider momentum, coupled with a modest share‑price uptick, could be a catalyst for renewed interest, provided the company successfully navigates its recent earnings decline and continues to implement cost‑control measures. Monitoring future insider filings and quarterly earnings will be essential to gauge whether this confidence translates into tangible financial recovery.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-03-16Dodson Vicki L (Sr.VP Patient Srvcs)Buy3,734.0053.94Shares of Common Stock held in my name
2026-03-16Dodson Vicki L (Sr.VP Patient Srvcs)Sell2,034.00164.96Shares of Common Stock held in my name
2026-03-16Dodson Vicki L (Sr.VP Patient Srvcs)Sell3,734.00N/AOption to Purchase Common Stock
2025-03-05Dodson Vicki L (Sr.VP Patient Srvcs)Holding8,000.00N/AOption to Purchase Common Stock
2026-02-24Dodson Vicki L (Sr.VP Patient Srvcs)Holding9,000.00N/AOption to Purchase Common Stock
2027-02-23Dodson Vicki L (Sr.VP Patient Srvcs)Holding14,000.00N/AOption to Purchase Common Stock